VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BHF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BHFBrighthouse Financial, Inc.
$65.27$3.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBHFQuarterly Financials

Brighthouse Financial, Inc. (BHF) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Brighthouse Financial, Inc. (BHF) quarterly income statement — complete revenue, gross profit & net income history

BHF Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue1.4B1.56B1.71B790M2.32B1.08B1.96B1.33B74M1.36B1.12B174M1.3B447M1.23B3.75B1.79B1.72B2.11B1.32B
Revenue Growth %-39.74%44.48%-12.99%-40.56%3035.14%-20.93%75.74%663.79%-94.29%204.7%-9.26%-95.35%-27.46%-73.95%-41.66%182.64%90.62%2867.74%1261.29%281.26%
Medical Costs & Claims637M697M836M376M2.33B-108M1.34B945M968M2.05B107M-2M1.46B1.29B114M1.1B-499M1.26B1.44B1.05B
Medical Cost Ratio %45.57%44.79%48.95%47.59%100.6%-10.03%68.16%71.11%1308.11%150.51%9.58%-1.15%112.49%288.37%9.26%29.29%-27.91%73.72%68.39%79.02%
Gross Profit761M859M872M414M-14M1.19B625M384M-894M-688M1.01B176M-162M-842M1.12B2.65B2.29B451M667M278M
Gross Margin %54.43%55.21%51.05%52.41%-0.6%110.03%31.84%28.89%-1208.11%-50.51%90.42%101.15%-12.49%-188.37%90.74%70.71%127.91%26.28%31.61%20.98%
Gross Profit Growth %5535.71%-27.51%39.52%7.81%98.43%272.24%-38.12%118.18%-451.85%18.29%-9.58%-93.35%-107.08%-286.7%67.47%852.52%1210.19%155%119.52%115.85%
Operating Expenses1.75B709M287M321M340M351M437M370M-280M486M420M413M491M482M605M471M284M402M177M257M
OpEx / Revenue %124.96%45.57%16.8%40.63%14.66%32.59%22.26%27.84%-378.38%35.68%37.6%237.36%37.86%107.83%49.15%12.58%15.88%23.43%8.39%19.4%
Depreciation & Amortization00000000000000000000
Combined Ratio %170.53%90.36%65.75%88.23%115.26%22.56%90.42%98.95%929.73%186.2%47.18%236.21%150.35%396.2%58.41%41.87%-12.02%97.14%76.78%98.42%
Operating Income-986M150M585M93M-354M834M188M14M-614M-1.17B590M-237M-653M-1.32B512M2.18B2B49M490M21M
Operating Margin %-70.53%9.64%34.25%11.77%-15.26%77.44%9.58%1.05%-829.73%-86.2%52.82%-136.21%-50.35%-296.2%41.59%58.13%112.02%2.86%23.22%1.58%
Operating Income Growth %-178.53%-82.01%211.17%564.29%42.35%171.04%-68.14%105.91%5.97%11.33%15.23%-110.89%-132.6%-2802.04%4.49%10266.67%360.81%103.75%112.75%100.83%
EBITDA-948M188M623M131M-316M872M226M52M-576M-1.14B628M-199M-615M-1.28B550M2.21B2.04B90M531M61M
EBITDA Margin %-67.81%12.08%36.48%16.58%-13.62%80.97%11.51%3.91%-778.38%-83.33%56.22%-114.37%-47.42%-287.47%44.68%59.15%114.15%5.24%25.17%4.6%
Interest Expense38M38M38M38M38M38M38M38M38M39M38M38M38M39M38M38M38M41M41M40M
Non-Operating Income-38M-38M-38M-38M-38M-38M-38M-38M-38M-39M-38M-38M-38M-39M-38M-38M-38M-41M-41M-40M
Pretax Income-986M150M585M93M-354M834M188M14M-614M-1.17B590M-237M-653M-1.32B512M2.18B2B49M490M21M
Pretax Margin %-70.53%9.64%34.25%11.77%-15.26%77.44%9.58%1.05%-829.73%-86.2%52.82%-136.21%-50.35%-296.2%41.59%58.13%112.02%2.86%23.22%1.58%
Income Tax-222M12M104M8M-88M162M10M-20M-123M-258M109M-62M-156M-384M97M432M416M-15M105M-10M
Effective Tax Rate %22.52%8%17.78%8.6%24.86%19.42%5.32%-142.86%20.03%21.98%18.47%26.16%23.89%29%18.95%19.84%20.77%-30.61%21.43%-47.62%
Net Income-766M137M479M85M-268M671M176M34M-493M-917M479M-175M-499M-941M413M1.75B1.58B63M383M31M
Net Margin %-54.79%8.8%28.04%10.76%-11.55%62.3%8.97%2.56%-666.22%-67.33%42.88%-100.57%-38.47%-210.51%33.55%46.6%88.65%3.67%18.15%2.34%
Net Income Growth %-185.82%-79.58%172.16%150%45.64%173.17%-63.26%119.43%1.2%2.55%15.98%-110.03%-131.48%-1593.65%7.83%5529.03%370.94%106.1%112.79%101.56%
EPS (Diluted)-13.721.947.891.02-5.0410.792.470.14-8.29-14.706.89-2.62-7.321.585.3922.9120.110.524.340.12
EPS Growth %-172.22%-82.02%219.43%628.57%39.2%173.4%-64.15%105.34%-13.25%-1030.38%27.83%-111.44%-136.4%203.85%24.19%18991.67%388.52%104.53%113.43%100.57%
EPS (Basic)-13.721.967.931.05-5.0411.022.480.15-8.29-14.706.93-3.00-7.731.615.4323.0420.270.544.370.12
Diluted Shares Outstanding57.74M57.83M57.73M57.73M58.26M60.95M60.95M62.26M62.26M64.08M65.74M66.72M67.87M68.28M71.96M74.97M75.8M80.24M83.24M86.07M